Evaluation of serum human telomerase reverse transcriptase as a novel marker for cervical cancer

International Journal of Biological Markers

Volumn 26, Issue 1, 2011, Pages 22-26

  Porika, Mahendar ^a   Tippani, Radhika ^a   Mohammad, Anwar ^b,c   Bollam, Sekhar R ^c   Panuganti, Sree D ^a   Abbagani, Sadanandam ^a  

^a KAKATIYA UNIVERSITY   (India)

^b Mahatma Gandhi Memorial Hospital   (India)

^c Rohini Hospital   (India)

Author keywords

Adenocarcinoma; Cervical cancer; Diagnosis; Human telomerase reverse transcriptase (hTERT); Squamous cell carcinoma; Tumor marker

Indexed keywords

CA 125 ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TELOMERASE REVERSE TRANSCRIPTASE;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERPINS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 79953650536     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2011.6352     Document Type: Article

References (28)

1. Park KJ, Soslow RA. Current concepts in cervical pathology. Arch Pathol Lab Med 2009; 133: 729-38.
2. Nair MK, Varghese C, Swaminathan R. Cancer: Current scenario, intervention strategies and projections for 2015. National Commission for Macroeconomics and Health Background papers-Burden of disease in India. New Delhi: Ministry of Health and Family Welfare, Government of India, 2005; 218-25.
3. Tsai CC, Liu YS, Huang EY, et al. Value of preoperative serum CA125 in early stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis. Gynecol Oncol 2006; 100: 591-5.
4. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6: 611-22
5. Kovalenko OA, Kaplunov J, Herbig U, deToledo S, Azzam EI, Santos JH. Expression of NES-hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress. PLoS One 2010; 5: 1-12.
6. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12: 1133-8.
7. Shay JW, Wright WE. Use of telomerase to create bioengineered tissues. Ann N Y Acad Sci 2005; 1057: 479-91.
8. Gabriele S. Telomerase, mitochondria and oxidative stress. Exp Gerontol 2009; 44: 485-92.
9. Hiyama E, Hiyama K, Yokoyama T, Shay JW. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001; 3: 17-26.
10. Mahendar P, Uday Kiran V, Radhika K, Radhika T, Rama Krishna D, Sadanandam A. Detection of telomerase activity in different cancer tissues: a diagnostic marker. Current Trends in Biotechnology and Pharmacy 2009; 3: 105-10.
11. Chang JT, Chen YL, Yang HT, Chen CY, Cheng AJ. Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem 2002; 269: 3442-50.
12. Norimasa M, Yoshiko M, Takamasa K, et al. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma Clin Cancer Res 2005; 11: 3205-9.
13. Hosseini-Asl S, Atri M, Modarressi MH, Salhab M, Mokbel K, Mehdipour P. The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters. Int Semin Surg Oncol 2006; 3: 20.
14. Francisco D, Salvador L, Eduardo GG, et al. Real-Time quantifcation in plasma of human telomerase reverse transcriptase (hTERT) mRNA: A simple blood test to monitor disease in cancer patients. Lab Invest 2001; 81: 767-9.
15. Novakovic S, Hocevar M, Zgajnar J, Besic N, Stegel V. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol Rep 2004; 11: 245-52.
16. Norimasa M, Yukio O, Miki N, et al. A novel biomarker TERT mRNA is applicable for early detection of hepatoma. BMC Gastroenterol 2010; 10: 1-12
17. Ramirez JL, Sarries C, de Castro PL, et al. Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Lett 2003; 193: 207-16.
18. Kim NW, Piatyszek MA, Prowse KR, et al. Specifc association of human telomerase activity with immortal cells and cancer. Science 1994; 226: 2011-5.
19. Colomer R, Ruibal A, Genolla J, Salvador L. Circulating CA15.3 antigen levels in non-mammary malignancies. Br J Cancer 1989; 59: 283-6.
20. Kirkpatrick KL, Ogunkolade W, Elkak AE, et al. hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat 2003; 77: 277-84.
21. Carolina OG, Mariana FL, Patricia NOS, et al. hTERT methylation and expression in gastric cancer. Biomarkers 2009; 14: 630-6.
22. Masutomi K, Shuichi K, Mami Y, Kuniaki A, Seishi M, Kenichi K. Identifcation of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma. Oncogene 2002; 21: 5946-50.
23. Norimasa M, Yasunobu K, Masakuni T, et al. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies. Oncol Rep 2007; 17: 541-8.
24. Rosa D, Stefania T, Rosanna L, et al. Circulating hTERT DNA in early breast cancer. Anticancer Res 2009; 29: 2845-9.
25. Mitsuhashi A, Matsui H, Usui H, et al. Serum YKL-40 as a marker for cervical adenocarcinoma. Ann Oncol 2009; 20: 71-7.
26. Toro de Méndez M, Llombart Bosch A. Immunohistochemical expression of ubiquitin and telomerase in cervical cancer. Virchows Arch 2009: 455: 235-43.
27. Li C, Wu MY, Liang YR, Wu XY. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9: 2395-9.
28. Norimasa M, Hiroshige N, Reina S, et. al. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Science 2006; 97: 1366-73.